Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Escalon MedicalESMC 34 Net Margin % is 90.95% as of Mar. 2026. GuruFocus rates ESMC with a GF Score™ of 34/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Escalon Medical ranks better than 84.31% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Escalon Medical's Net Income for the
three
months ended in Mar. 2026 was $2.37 Mil. Escalon Medical's Revenue for the
three
months ended in Mar. 2026 was $2.61 Mil. Therefore, Escalon Medical's net margin for the quarter that ended in Mar. 2026 was 90.95%.
The historical rank and industry rank for Escalon Medical's Net Margin % or its related term are showing as below:
ESMC'
s Net Margin % Range Over the Past 10 Years
Min: -9.95 Med: -0.77 Max: 16.17
Current: 16.17
ESMC's Net Margin % is ranked better than 84.31% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs ESMC: 16.17
Escalon Medical (OTCPK:ESMC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Escalon Medical Net Margin % Related Terms
Escalon Medical Net Margin % Historical Data
* Premium members only.
The historical data trend for Escalon Medical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Escalon Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Escalon Medical Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Net Margin % distribution charts can be found below:
* The bar in red indicates where Escalon Medical's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical (ESMC) has a Net Margin % of 90.95% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Escalon Medical and its competitors. According to the industry distribution chart, Escalon Medical ranks #128 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 15.7%.
Is Escalon Medical's Net Margin % too high?
Escalon Medical's current Net Margin % is 90.95%. The Medical Devices & Instruments industry median Net Margin % is 2.07. Escalon Medical's value of 90.95% is 4293.7% above this industry median. Based on the distribution chart, Escalon Medical ranks #128 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Escalon Medical has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Escalon Medical's Net Margin % compare to RBOT and NUWE?
According to the Medical Devices & Instruments industry distribution chart, Escalon Medical ranks #128 out of 816 companies for Net Margin %. This places Escalon Medical in the top 16% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Escalon Medical's value of 90.95% is 4293.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Escalon Medical's current Net Margin % of 90.95% is 4293.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Escalon Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Escalon Medical's current Net Margin % is 90.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Escalon Medical stock overvalued right now?
Based on GuruFocus' analysis, Escalon Medical (ESMC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $0.20 — trading 33.3% above its estimated fair value. The current Net Margin % is 90.95% and 4293.7% above the Medical Devices & Instruments industry median of 2.07. Escalon Medical's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Escalon Medical (ESMC), the current Net Margin % is 90.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Escalon Medical (ESMC) Overvalued in 2026?
Based on GuruFocus' analysis, Escalon Medical stock appears to be overvalued.
The current stock price of $0.20 is trading 33.3% above its estimated GF Value™ of $0.15.
GuruFocus considers Escalon Medical to be Significantly Overvalued.
Key valuation signals for ESMC:
Net Margin %: 90.95%
GF Value™: $0.15 vs. price of $0.20 (33.3% above fair value)
Industry Position: 4293.7% above the Medical Devices & Instruments median (#128 of 816)
No single metric tells the full story. See the ESMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Escalon Medical Corp operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
34GF Score
Get the complete analysis for ESMC
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESMC has been successfully added to your 
